MaartenTaal United KingdomUniversity of Nottingham

MaartenTaal
Maarten Taal MBChB, MMed, MD, FCP(SA), FRCP Maarten graduated from the University of Cape Town Medical School, South Africa, in 1987. After completing his post-graduate training in internal medicine and nephrology at Groote Schuur Hospital, Cape Town, he joined the Laboratory of Kidney and Electrolyte Physiology at Brigham and Women’s Hospital, Boston, USA under the directorship of Barry M. Brenner, MD. His research focused on mechanisms underlying the progression of chronic kidney disease (CKD) and earned him a Doctor of Medicine degree. He subsequently moved to the United Kingdom. He was appointed Professor of Medicine at the University on Nottingham in 2014, where he leads the Centre for Kidney Research and Innovation. He is a Past President of the British Renal Society and current Chair of the International Network of CKD Cohorts. He is Editor-in-Chief of “Current Opinion in Nephrology and Hypertension”, Co-Editor for “Brenner and Rector’s The Kidney”, Academic Editor for “PLOS Medicine” and is on the Editorial Board for “American Journal of Kidney Diseases”.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
LF01
ElianaDina-Batlle Chairperson Dradina@mac.comDominican RepublicHospital Metropolitano De Santiago Pontificia Universidad Católica Madre y Maestra
GustavoLaham Chairperson glaham@cemic.edu.arArgentinaGustavo Laham, Sociedad Argentina de Nefrología (SAN)
OlynkaVega Chairperson olynkavega@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Updates on Uremic Toxins
    ZiadMassy Speaker ziad.massy@apr.aphp.frFranceGlobal Medical Director, AURA, Paris
  • Bringing Nobel Prize Winning Discoveries in Oxygen Sensing to Nephrology Clinics
    Kai-UweEckardt Speaker GermanyDepartment of Nephrology and Medical Intensive Car
  • A Look Forward: Clinical Implications of Translational Research in CKD-MBD
    HirotakaKomaba Speaker hkomaba@tokai-u.jpJapanTokai University School of Medicine
  • Challenges and Opportunities for Translating Anti-inflammatory Therapeutics into Treatments for Patients With Kidney Failure
    LauraDember Speaker ldember@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania
  • Q/A
Hall E
10:30 a.m.
11 a.m.
SPOT-O3
JonathanBarratt Spotlight Speaker United KingdomUniversity of Leicester, Leicester, UK
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
PL2
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja
Hall A
12:15 p.m.
1:15 p.m.
CHAL02
JavierDe Arteaga Chairperson javierdearteaga@gmail.comArgentinaHospital Privado Universitario de Cordoba. Catholic University from Cordoba
KarinaSoto Chairperson ksoto.nefro@gmail.comPortugalCentro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de Lisboa
SandraHerrmann Chairperson herrmann.sandra@mayo.eduUnited StatesMayo Clinic
  • AKI-related Cancer and Cancer Treatment-related TMA
    ClaraGarcía Carro Speaker claragarciacarro@hotmail.comSpainSan Carlos Clinical Hospital (Madrid, Spain)
  • AKI Related to Cancer Immunotherapy: Can Biomarkers Help?
    SebastianLapman Speaker lapseba@yahoo.com.arArgentina
  • Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology
    JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
  • Q and A
Hall E
3 p.m.
4 p.m.
IK01
FelipeInserra Chairperson felipe.inserra@gmail.comArgentina
YelenaDrexler Chairperson yrd6@miami.eduUnited StatesUniversity of Miami Miller School of Medicine
  • New Insights into the Mechanisms of Kidney Injury in the CRS
    WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States
  • Novel Pharmacological Treatments of the CRS
    MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center
  • Device-related Treatment for CRS
    ClaudioRonco Speaker cronco@goldnet.itItalyInternational Renal Research Institute of Vicenza
  • Q and A
Hall D
4:30 p.m.
5:30 p.m.
IK1001
MaartenTaal Chairperson United KingdomUniversity of Nottingham
RobertoPecoits Filho Chairperson United StatesArbor Research Collaborative for Health
  • Big Data Lab
    LAB-01
  • Patient-reported Outcome Measures: How Do Patients Experience CKD?
    AdeeraLevin Speaker CanadaUniversity of British Columbia and Providence Health Care
  • Trial Simulation Using Observational Data
    AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health
  • Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges
    DorotheaNitsch Speaker United KingdomLondon School of Hygiene & Tropical Medicine
  • Q and A
Hall C4

Day 2 - Monday April 15, 2024

Time Session
11 a.m.
12 p.m.
PL3
Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)
MegJardine Chairperson AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia
  • Generative AI Revolution in Medicine
    MichalRosen-Zvi Speaker ROSEN@il.ibm.comIsraelhttps://research.ibm.com/
  • Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh)
    Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh
Hall A
3 p.m.
4 p.m.
LBCT
AlessiaFornoni Chairperson United StatesUniversity of Miami
MichelleRheault Chairperson rheau002@umn.eduUnited StatesUniversity of Minnesota
  • Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
    PietroRavani Free Communication pravani@ucalgary.caCanadaUniversity of Calgary
  • Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
    Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkDenmarkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research Consultant
  • EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
    DanaRizk Free Communication drizk@uabmc.eduUnited StatesUniversity of Alabama at Birmingham
  • SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
    JonathanBarratt Free Communication United KingdomUniversity of Leicester, Leicester, UK
  • PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
    CécileCouchoud Free Communication cecile.couchoud@biomedecine.frFranceREIN registry, Agence de la biomédecine, France
Hall A
4:30 p.m.
5:30 p.m.
CHAL05
CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal
Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina
  • MGRS: Should All Forms Need Clonal Therapy?
    FrankBridoux Speaker f.bridoux@chu-poitiers.frFranceDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, France
  • Renal Amyloidosis: What Is New?
    Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brBrazilSão Paulo State Cancer Institute - University of São Paulo
  • Can We Perform a Transplant in Patients with Myeloma and Amyloidosis?
    SabineKaram Speaker United StatesUniversity of Minnesota
  • Q and A
Hall A

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10:30 a.m.
SK06
Juan ManuelMejia Vilet Chairperson jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
ValeriaAlberton Chairperson vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce
  • Updates on IgAN Management
    HernánTrimarchi Speaker ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES
  • Membranous GN Classification and Management
    PierreRonco Speaker FranceHôpital Tenon
  • MPGN Updates
    SanjeevSethi Speaker United StatesMayo Clinic
  • Managing Vasculitis
    RobertaFenoglio Speaker roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco
  • Q and A
Hall A
11 a.m.
12:15 p.m.
PL4
AlessiaFornoni Chairperson United StatesUniversity of Miami
LizLightstone Chairperson United KingdomImperial College London
MasaomiNangaku Chairperson Japan
  • Acceptance Speech: Bywaters Award
    MotokoYanagita Speaker JapanKyoto University
  • Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture
    EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa
  • ELP2 Graduation
    MasaomiNangaku Speaker Japan
Hall A